Shots:

• In addition to the single-dose regimen ENSEMBLE study- Janssen has now initiated the two-dose regimen ENSEMBLE 2 trial in collaboration with the UK NIHR
• The P-lll ENSEMBLE 2 study will evaluate the safety and efficacy of a two-dose regimen of the investigational Janssen vaccine for the prevention of COVID-19 in ~30-000 patients across the globe. The ENSEMBLE and ENSEMBLE 2 trials will run in parallel
• The two P-III studies follow positive interim results of P-I/IIa study assessing the safety profile and immunogenicity of both a single-dose/ two-dose vaccination

 ­ Ref: Janssen | Image: Philadelphia Inquirer